[1]
|
Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., Li, J., Zhao, D., Xu, D., Gong, Q., et al. (2020) Clinical Characteristics and Intrauterine Vertical Transmission Potential of Covid-19 Infection in Nine Pregnant Women: A Retrospective Review of Medical Records. The Lancet, 395, 809-815. https://doi.org/10.1016/S0140-6736(20)30360-3
|
[2]
|
Rothan, H.A. and Byrareddy, S.N. (2020) The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. Journal of Autoimmunity, 109, Article ID: 102433. https://doi.org/10.1016/j.jaut.2020.102433
|
[3]
|
Guo, Y.-R., Cao, Q.-D., Hong, Z.-S., Tan, Y.-Y., Chen, S.-D., Jin, H.-J., Tan, K.-S., Wang, D.-Y. and Yan, Y. (2020) The Origin, Transmission and Clinical Therapies on Coronavirus Disease 2019 (COVID-19) Outbreak—An Update on the Status. Military Medical Research, 7, Article No. 11. https://doi.org/10.1186/s40779-020-00240-0
|
[4]
|
Tu, Y.-F., Chien, C.-S., Yarmishyn, A.A., Lin, Y.-Y., Luo, Y.-H., Lin, Y.-T., Lai, W.-Y., Yang, D.-M., Chou, S., Yang, Y.-P., et al. (2020) A Review of Sars-cov-2 and the Ongoing Clinical Trials. International Journal of Molecular Sciences, 21, Article No. 2657. https://doi.org/10.3390/ijms21072657
|
[5]
|
Wang, L., Wang, Y., Ye, D. and Liu, Q. (2020) Review of the 2019 Novel Coronavirus (SARS-CoV-2) Based on Current Evidence. International Journal of Antimicrobial Agents, 55, Article ID: 105948. https://doi.org/10.1016/j.ijantimicag.2020.105948
|
[6]
|
World Health Organization (n.d.) Coronavirus Disease (COVID-19) Pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
|
[7]
|
Sharma, O., Sultan, A.A., Ding, H. and Triggle, C.R. (2020) A Review of the Progress and Challenges of Developing a Vaccine for Covid19. Frontiers in Immunology, 11, Article No. 585354. https://doi.org/10.3389/fimmu.2020.585354
|
[8]
|
Voysey, M., Clemens, S.A.C., Madhi, S.A., Weckx, L.Y., Folegatti, P.M., Aley, P.K., Angus, B., Baillie, V.L., Barnabas, S.L., Bhorat, Q.E., et al. (2021) Safety and Efficacy of the Chadox1 Ncov-19 Vaccine (azd1222) Against Sars-cov-2: An Interim Analysis of Four Randomised Controlled Trials in Brazil, South Africa, and the UK. The Lancet, 397, 99-111. https://doi.org/10.1016/S0140-6736(20)32661-1
|
[9]
|
Corbett, K.S., Flynn, B., Foulds, K.E., Francica, J.R., Boyoglu-Barnum, S., Werner, A.P., Flach, B., O’Connell, S., Bock, K.W., Minai, M., et al. (2020) Evaluation of the Mrna-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates. New England Journal of Medicine, 383, 1544-1555. https://doi.org/10.1056/NEJMoa2024671
|
[10]
|
Baden, L.R., El Sahly, H.M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S.A., Rouphael, N., Buddy Creech, C., et al. (2021) Efficacy and Safety of the Mrna-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine, 384, 403-416. https://doi.org/10.1056/NEJMoa2035389
|
[11]
|
Anderson, E.J., Rouphael, N.G., Widge, A.T., Jackson, L.A., Roberts, P.C., Makhene, M., Chappell, J.D., Denison, M.R., Stevens, L.J., Pruijssers, A.J., et al. (2020) Safety and Immunogenicity of Sars-cov-2 Mrna-1273 Vaccine in Older Adults. New England Journal of Medicine, 383, 2427-2438. https://doi.org/10.1056/NEJMoa2028436
|
[12]
|
Zhang, Y.-J., Zeng, G., Pan, H.-X., Li, C.-G., Kan, B., Hu, Y.-L., Mao, H.-Y., Xin, Q.-Q., Chu, K., Han, W.-X., et al. (2020) Immunogenicity and Safety of a Sars-cov-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years: Report of the Randomized, Double-Blind, and Placebo-Controlled Phase 2 Clinical Trial. Medrxiv. https://doi.org/10.1101/2020.07.31.20161216
|
[13]
|
Jones, I. and Roy, P. (2021) Sputnik V COVID-19 Vaccine Candidate Appears Safe and Effective. The Lancet, 397, 642-643. https://doi.org/10.1016/S0140-6736(21)00191-4
|
[14]
|
Burki, T.K. (2020) The Russian Vaccine for COVID-19. The Lancet Respiratory Medicine, 8, e85-e86. https://doi.org/10.1016/S2213-2600(20)30402-1
|
[15]
|
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C. and Yang, C. (2020) Nervous System Involvement after Infection With Covid-19 and other Coronaviruses. Brain, Behavior, and Immunity, 87, 18-22. https://doi.org/10.1016/j.bbi.2020.03.031
|
[16]
|
Chhikara, B.S., Rathi, B., Singh, J. and Poonam, F.N.U. (2020) Corona Virus Sars-CoV-2 Disease COVID-19: Infection, Prevention and Clinical Advances of the Prospective Chemical Drug Therapeutics. Chemical Biology Letters, 7, 63-72. https://doi.org/10.1007/s00058-020-1496-8
|
[17]
|
Liang, Y., Wang, M.-L., Chien, C.-S., Yarmishyn, A.A., Yang, Y.-P., Lai, W.-Y., Luo, Y.-H., Lin, Y.-T., Chen, Y.-J., Chang, P.-C., et al. (2020) Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection. Frontiers in Immunology, 11, Article No. 1022. https://doi.org/10.3389/fimmu.2020.01022
|
[18]
|
Zhang, H., Penninger, J.M., Li, Y., Zhong, N. and Slutsky, A.S. (2020) Angiotensin-Converting Enzyme 2 (ACE2) as a SARS-CoV-2 Receptor: Molecular Mechanisms and Potential Therapeutic Target. Intensive Care Medicine, 46, 586-590. https://doi.org/10.1007/s00134-020-05985-9
|
[19]
|
Li, W., Moore, M.J., Vasilieva, N., Sui, J., Wong, S.K., Berne, M.A., Somasundaran, M., Sullivan, J.L., Luzuriaga, K., Greenough, T.C., et al. (2003) Angiotensin-Converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus. Nature, 426, 450-454. https://doi.org/10.1038/nature02145
|
[20]
|
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) A Crucial Role of Angiotensin Converting Enzyme 2 (ACE2) in SARS Coronavirus-Induced Lung Injury. Nature Medicine, 11, 875-879. https://doi.org/10.1038/nm1267
|
[21]
|
Xiu, S., Dick, A., Ju, H., Mirzaie, S., Abdi, F., Cocklin, S., Zhan, P. and Liu, X. (2020) Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities. Journal of Medicinal Chemistry, 63, 12256-12274. https://doi.org/10.1021/acs.jmedchem.0c00502
|
[22]
|
Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y. and Du, L. (2020) Characterization of the Receptor-Binding Domain (RBD) of 2019 Novel Coronavirus: Implication for Development of RBD Protein as a Viral Attachment Inhibitor and Vaccine. Cellular & Molecular Immunology, 17, 613-620. https://doi.org/10.1038/s41423-020-0400-4
|
[23]
|
Spinello, A., Saltalamacchia, A. and Alessandra, M. (2020) Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atom Simulations. The Journal of Physical Chemistry Letters, 11, 4785-4790. https://doi.org/10.1021/acs.jpclett.0c01148
|
[24]
|
Han, Y. and Král, P. (2020) Computational Design of Ace2-Based Pep-Tide Inhibitors of SARS-CoV-2. ACS Nano, 14, 5143-5147. https://doi.org/10.1021/acsnano.0c02857
|
[25]
|
Singh, A., Steinkellner, G., Köchl, K., Gruber, K. and Gruber, C.C. (2021) Serine 477 Plays a Crucial Role in the Interaction of the SARS-CoV-2 Spike Protein with the Human Receptor ACE2. Scientific Reports, 11, Article No. 4320. https://doi.org/10.1038/s41598-021-83761-5
|
[26]
|
Basu, A., Sarkar, A. and Maulik, U. (2020) Molecular Docking Study of Potential Phytochemicals and Their Effects on the Complex of SARS-CoV2 Spike Protein and Human ACE2. Scientific Reports, 10, Article No. 17699. https://doi.org/10.1038/s41598-020-74715-4
|
[27]
|
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W. and Cheng, F. (2020) Network-Based Drug Repurposing for Novel Coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6, Article No. 4. https://doi.org/10.1038/s41421-020-0153-3
|
[28]
|
Gordon, D.E., Jang, G.M., Bouhaddou, M., Xu, J., Obernier, K., White, K.M., OMeara, M.J., Rezelj, V.V., Guo, J.Z., Swaney, D.L., et al. (2020) A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing. Nature, 583, 459-468. https://doi.org/10.1038/s41586-020-2286-9
|
[29]
|
Pandey, A., Nikam, A.N., Shreya, A.B., Mutalik, S.P., Gopalan, D., Kulkarni, S., Padya, B.S., Fernandes, G., Mutalik, S. and Prassl, R. (2020) Potential Therapeutic Targets for Combating SARS-CoV-2: Drug Repurposing, Clinical Trials and Recent Advancements. Life Sciences, 256, Article ID: 117883. https://doi.org/10.1016/j.lfs.2020.117883
|
[30]
|
Swain, S.S., Panda, S.K. and Luyten, W. (2020) Phytochemicals against SARS-CoV as Potential Drug Leads. Biomedical Journal, 44, 74-85.
|
[31]
|
Panche, A.N., Diwan, A.D. and Chandra, S.R. (2016) Flavonoids: An Overview. Journal of Nutritional Science, 5, Article No. e47. https://doi.org/10.1017/jns.2016.41
|
[32]
|
Harborne, J.B., Marby, H. and Marby, T.J. (2013) The Flavonoids. Springer, Boston.
|
[33]
|
Hertog, M.G.L., Hollman, P.C.H. and Katan, M.B. (1992) Content of Potentially Anticarcinogenic Flavonoids of 28 Vegetables and 9 Fruits Commonly Consumed in the Netherlands. Journal of Agricultural and Food Chemistry, 40, 2379-2383. https://doi.org/10.1021/jf00024a011
|
[34]
|
Kumar, S. and Pandey, A.K. (2013) Chemistry and Biological Activities of Flavonoids: An Overview. The Scientific World Journal, 2013, Article ID: 162750. https://doi.org/10.1155/2013/162750
|
[35]
|
Sharma, D.K. (2006) Pharmacological Properties of Flavonoids Including Flavonolignans-Integration of Petrocrops with Drug Development from Plants. Journal of Scientific and Industrial Research, 65, 477-484.
|
[36]
|
Kim, H.P., Son, K.H., Chang, H.W. and Kang, S.S. (2004) Anti-Inflammatory Plant Flavonoids and Cellular Action Mechanisms. Journal of Pharmacological Sciences, 96, 229-245. https://doi.org/10.1254/jphs.CRJ04003X
|
[37]
|
Cushnie, T.P. and Lamb, A.J. (2005) Antimicrobial Activity of Flavonoids. International Journal of Antimicrobial Agents, 26, 343-356. https://doi.org/10.1016/j.ijantimicag.2005.09.002
|
[38]
|
Lehane, A.M. and Saliba, K.J. (2008) Common Dietary Flavonoids Inhibit the Growth of the Intraerythrocytic Malaria Parasite. BMC Research Notes, 1, Article No. 26. https://doi.org/10.1186/1756-0500-1-26
|
[39]
|
Muzitano, M.F., Falcão, C.A.B., Cruz, E.A., Bergonzi, M.C., Bilia, A.R., Vincieri, F.F., Rossi-Bergmann, B. and Costa, S.S. (2009) Oral Metabolism and Efficacy of Kalanchoe Pinnata Flavonoids in a Murine Model of Cutaneous Leishmaniasis. Planta Medica, 75, 307-311. https://doi.org/10.1055/s-0028-1088382
|
[40]
|
Marín, C., Ramírez-Macías, I., López-Céspedes, A., Olmo, F., Villegas, N., Díaz, J.G., Rosales, M.J., Gutiérrez-Sánchez, R. and Sánchez-Moreno, M. (2011) In Vitro and in Vivo Trypanocidal Activity of Flavonoids from Delphinium Staphisagria against Chagas Disease. Journal of Natural Products, 74, 744-750. https://doi.org/10.1021/np1008043
|
[41]
|
Sanchez, I., Gómez-Garibay, F., Taboada, J. and Ruiz, B.H. (2000) Antiviral Effect of Flavonoids on the Dengue Virus. Phytotherapy Research, 14, 89-92. https://doi.org/10.1002/(SICI)1099-1573(200003)14:2%3C89::AID-PTR569%3E3.0.CO;2-C
|
[42]
|
Kiat, T.S., Pippen, R., Yusof, R., Ibrahim, H., Khalid, N., and Abd Rahman, N. (2006) Inhibitory Activity of Cyclohexenyl Chalcone Derivatives and Flavonoids of Fingerroot, Boesenbergia Rotunda (L.), towards Dengue-2 Virus NS3 Protease. Bioorganic & Medicinal Chemistry Letters, 16, 3337-3340. https://doi.org/10.1016/j.bmcl.2005.12.075
|
[43]
|
de Sousa, L.R.F., Wu, H., Nebo, L., Fernandes, J.B., Kiefer, W., Kanitz, M., Bodem, J., Diederich, W.E., Schirmeister, T., Vieira, P.C., et al. (2015) Flavonoids as Noncompetitive Inhibitors of Dengue Virus NS2B-NS3 Pro-Tease: Inhibition Kinetics and Docking Studies. Bioorganic & Medicinal Chemistry, 23, 466-470. https://doi.org/10.1016/j.bmc.2014.12.015
|
[44]
|
Abotaleb, M., Samuel, S.M., Varghese, E., Varghese, S., Kubatka, P., Liskova, A. and Büsselberg, D. (2019) Flavonoids in Cancer and Apoptosis. Cancers, 11, Article No. 28. https://doi.org/10.3390/cancers11010028
|
[45]
|
Wang, H.-K. (2000) The Therapeutic Potential of Flavonoids. Expert Opinion on Investigational Drugs, 9, 2103-2119. https://doi.org/10.1517/13543784.9.9.2103
|
[46]
|
Park, E.-J. and Pezzuto, J.M. (2012) Flavonoids in Cancer Prevention. Anti-Cancer Agents in Medicinal Chemistry, 12, 836-851. https://doi.org/10.2174/187152012802650075
|
[47]
|
Yu, R., Chen, L., Lan, R., Shen, R. and Li, P. (2020) Computational Screening of Antagonists against the SARS-CoV-2 (COVID-19) Coronavirus by Molecular Docking. International Journal of Antimicrobial Agents, 56, Article ID: 106012. https://doi.org/10.1016/j.ijantimicag.2020.106012
|
[48]
|
Muchtaridi, M., Fauzi, M., Ikram, N.K.K., Gazzali, A.M. and Wahab, H.A. (2020) Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2. Molecules, 25, Article No. 3980. https://doi.org/10.3390/molecules25173980
|
[49]
|
Ngwa, W., Kumar, R., Thompson, D., Lyerly, W., Moore, R., Reid, T.-E., Lowe, H. and Toyang, N. (2020) Potential of Flavonoid-Inspired Phytomedicines against Covid-19. Molecules, 25, Article No. 2707. https://doi.org/10.3390/molecules25112707
|
[50]
|
Pandey, P., Rane, J.S., Chatterjee, A., Kumar, A., Khan, R., Prakash, A. and Ray, S. (2020) Targeting SARS-cov-2 Spike Protein of Covid-19 with Naturally Occurring Phytochemicals: An in Silico Study for Drug Development. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1862705
|
[51]
|
Dolzhenko, Y., Bertea, C.M., Occhipinti, A., Bossi, S. and Maffei, M.E. (2010) UV-B Modulates the Interplay between Terpenoids and Flavonoids in Peppermint (Menthe × Piperita L.). Journal of Photochemistry and Photobiology B: Biology, 100, 67-75. https://doi.org/10.1016/j.jphotobiol.2010.05.003
|
[52]
|
McKay, D.L. and Blumberg, J.B. (2006) A Review of the Bioactivity and Potential Health Benefits of Chamomile Tea (Matricaria recutita L.). Phytotherapy Research, 20, 519-530. https://doi.org/10.1002/ptr.1900
|
[53]
|
Bodalska, A., Kowalczyk, A., Wlodarczyk, M. and Fecka, I. (2020) Analysis of Polyphenolic Composition of a Herbal Medicinal Product Peppermint Tincture. Molecules, 25, Article No. 69. https://doi.org/10.3390/molecules25010069
|
[54]
|
Areias, F.M., Valentao, P., Andrade, P.B., Ferreres, F. and Seabra, R.M. (2001) Phenolic Fingerprint of Peppermint Leaves. Food Chemistry, 73, 307-311. https://doi.org/10.1016/S0308-8146(00)00302-2
|
[55]
|
Riachi, L.G. and De Maria, C.A.B. (2015) Peppermint Antioxidants Revisited. Food Chemistry, 176, 72-81. https://doi.org/10.1016/j.foodchem.2014.12.028
|
[56]
|
Mahendran, G. and Rahman, L.-U. (2020) Ethnomedicinal, Phytochemical and Pharmacological Updates on Peppermint (mentha× Piperita L.): A Review. Phytotherapy Research, 34, 2088-2139. https://doi.org/10.1002/ptr.6664
|
[57]
|
Peterson, J. and Dwyer, J. (1998) Flavonoids: Dietary Occurrence and Biochemical Activity. Nutrition Research, 18, 1995-2018. https://doi.org/10.1016/S0271-5317(98)00169-9
|
[58]
|
de Oliveira, O.V., Rocha, G.B., Paluch, A.S. and Costa, L.T. (2020) Repurposing Approved Drugs As Inhibitors of SARS-CoV-2 S-Protein From Molecular Modeling and Virtual Screening. Journal of Biomolecular Structure and Dynamics, 39, 2924-2933. https://doi.org/10.1080/07391102.2020.1772885
|
[59]
|
Muhseen, Z.T., Hameed, A.R., Al-Hasani, H.M.H., Ul Qamar, M.T. and Li, G. (2020) Promising Terpenes as SARS-CoV-2 Spike Receptor-Binding Domain (RBD) Attachment Inhibitors to the Human ACE2 Receptor: Integrated Computational Approach. Journal of Molecular Liquids, 320, Article ID: 114493. https://doi.org/10.1016/j.molliq.2020.114493
|
[60]
|
Hu, X., Cai, X., Song, X., Li, C., Zhao, J., Luo, W., Zhang, Q., Otte Ekumi, I. and He, Z. (2020) Possible Sarscoronavirus 2 Inhibitor Revealed by Simulated Molecular Docking to Viral Main Protease and Host Toll-Like Receptor. Future Virology, 15, 359-368. https://doi.org/10.2217/fvl-2020-0099
|
[61]
|
Istifli, E.S., Netz, P.A., Tepe, A.S., Husunet, M.T., Sarikurkcu, C. and Tepe, B. (2020) In Silico Analysis of the Interactions of Certain Flavonoids with the Receptor-Binding Domain of 2019 Novel Coronavirus and Cellular Proteases and Their Pharmacokinetic Properties. Journal of Biomolecular Structure and Dynamics, 40, 2460-2474. https://doi.org/10.1080/07391102.2020.1840444
|
[62]
|
Peterson, L. (2020) Covid-19 and Flavonoids: In Silico Molecular Dynamics Docking to the Active Catalytic Site of SARS-CoV and SARS-CoV-2 Main Protease. Social Science Research Network, Article ID: 3599426. https://doi.org/10.2139/ssrn.3599426
|
[63]
|
Das, S., Sarmah, S., Lyndem, S. and Roy, A.S. (2020) An Investigation into the Identification of Potential Inhibitors of Sars-cov-2 Main Protease Using Molecular Docking Study. Journal of Biomolecular Structure and Dynamics, 39, 3347-3357. https://doi.org/10.1080/07391102.2020.1763201
|
[64]
|
Russo, M., Moccia, S., Spagnuolo, C., Tedesco, I. and Russo, G.L. (2020) Roles of Flavonoids against Coronavirus Infection. Chemico-Biological Interactions, 328, Article ID: 109211. https://doi.org/10.1016/j.cbi.2020.109211
|
[65]
|
Bojadzic, D., Alcazar, O., Chen, J. and Buchwald, P. (2020) Small-Molecule in Vitro Inhibitors of the Coronavirus Spike-ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2. ACS Infectious Diseases, 7, 1519-1534. https://doi.org/10.1021/acsinfecdis.1c00070
|
[66]
|
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) Structure of the Sars-cov-2 Spike Receptor-Binding Domain Bound to the Ace2 Receptor. Nature, 581, 215-220. https://doi.org/10.1038/s41586-020-2180-5
|
[67]
|
National Library of Medicine—Pubchem. https://pubchem.ncbi.nlm.nih.gov/
|
[68]
|
Grosdidier, A., Zoete, V. and Michielin, O. (2011) Fast Docking Using the Charmm Force Field with EADock DSS. Journal of Computational Chemistry, 32, 2149-2159. https://doi.org/10.1002/jcc.21797
|
[69]
|
Grosdidier, A., Zoete, V. and Michielin, O. (2011) Swissdock, A Protein-Small Molecule Docking Web Service Based on EADock DSS. Nucleic Acids Research, 39, W270-W277. https://doi.org/10.1093/nar/gkr366
|
[70]
|
Cheng, B. and Li, T. (2020) Discovery of Alliin as a Putative Inhibitor of the Main Protease of SARS-CoV-2 by Molecular Docking. BioTechniques, 69, 108-112. https://doi.org/10.2144/btn-2020-0038
|
[71]
|
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C. and Ferrin, T.E. (2004) UCSF Chimera—A Visualization System for Exploratory Research and Analysis. Journal of Computational Chemistry, 25, 1605-1612. https://doi.org/10.1002/jcc.20084
|
[72]
|
Salentin, S., Schreiber, S., Joachim Haupt, V., Adasme, M.F. and Schroeder, M. (2015) PLIP: Fully Automated Protein-Ligand Interaction Profiler. Nucleic Acids Research, 43, W443-W447. https://doi.org/10.1093/nar/gkv315
|
[73]
|
Luan, B., Huynh, T., Cheng, X., Lan, G. and Wang, H.-R. (2020) Targeting Proteases for Treating Covid-19. Journal of Proteome Research, 19, 4316-4326. https://doi.org/10.1021/acs.jproteome.0c00430
|
[74]
|
Alexpandi, R., De Mesquita, J.F., Pandian, S.K. and Ravi, A.V. (2020) Quinolines-based Sars-cov2 3clpro and Rdrp Inhibitors and Spike-rbd-ace2 Inhibitor for Drugrepurposing Against Covid-19: An in Silico Analysis. Frontiers in Microbiology, 11, Article No. 1796. https://doi.org/10.3389/fmicb.2020.01796
|
[75]
|
Choudhary, S., Malik, Y.S. and Tomar, S. (2020) Identification of Sars-cov-2 Cell Entry Inhibitors by Drug Repurposing Using in Silico Structure-Based Virtual Screening Approach. Frontiers in Immunology, 11, Article No. 1664. https://doi.org/10.3389/fimmu.2020.01664
|
[76]
|
Trezza, A., Iovinelli, D., Santucci, A., Prischi, F. and Spiga, O. (2020) An Integrated Drug Repurposing Strategy for the Rapid Identification of Potential SARS-CoV-2 Viral Inhibitors. Scientific Reports, 10, Article No. 13866. https://doi.org/10.1038/s41598-020-70863-9
|
[77]
|
Wei, T.-Z., Wang, H., Wu, X.-Q., Lu, Y., Guan, S.-H., Dong, F.-Q., Zhu, G., Bao, Y.-Z., Zhang, J., Wang, G.-Y., et al. (2020) In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy. Chinese Journal of Integrative Medicine, 26, 663-669. https://doi.org/10.1007/s11655-020-3427-6
|
[78]
|
Panda, P.K., Arul, M.N., Patel, P., Verma, S.K., Luo, W., Rubahn, H.-G., Mishra, Y.K., Suar, M. and Ahuja, R. (2020) Structure-Based Drug Designing and Immunoinformatics Approach for SARS-CoV-2. Science Advances, 6, Article ID: eabb8097. https://doi.org/10.1126/sciadv.abb8097
|
[79]
|
Utomo, R.Y., Meiyanto, E. and Meiyanto, E. (2020) Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection. Preprints, 2020, Article ID: 2020030214. https://doi.org/10.1126/sciadv.abb8097
|
[80]
|
Cherrak, S.A., Merzouk, H. and Mokhtari-Soulimane, N. (2020) Potential Bioactive Glycosylated Flavonoids as SARS-CoV-2 Main Protease Inhibitors: A Molecular Docking and Simulation Studies. PLoS ONE, 15, Article ID: e0240653. https://doi.org/10.1371/journal.pone.0240653
|
[81]
|
Bhowmik, D., Nandi, R., Prakash, A. and Kumar, D. (2021) Evaluation of Flavonoids as 2019-nCoV Cell Entry Inhibitor through Molecular Docking and Pharmacological Analysis. Heliyon, 7, Article ID: e06515. https://doi.org/10.1016/j.heliyon.2021.e06515
|
[82]
|
Lal Badshah, S., Faisal, S., Akhtar, M., Benjamin Gabriel, P., Abdul Hamid, E. and Mariusz, J. (2021) Antiviral Activities of Flavonoids. Biomedicine & Pharmacotherapy, 140, Article ID: 111596. https://doi.org/10.1016/j.biopha.2021.111596
|
[83]
|
Abian, O., Ortega-Alarcon, D., Jimenez-Alesanco, A., Ceballos-Laita, L., Vega, S., Reyburn, H.T., Rizzuti, B. and Velazquez-Campoy, A. (2020) Structural Stability of Sars-CoV-2 3CLpro and Identification of Quercetin as an Inhibitor by Experimental Screening. International Journal of Biological Macromolecules, 164, 1693-1703. https://doi.org/10.1016/j.ijbiomac.2020.07.235
|
[84]
|
Liskova, A., Samec, M., Koklesova, L., Samuel, S.M., Zhai, K., Al-Ishaq, R.K., Abotaleb, M., Nosal, V., Kajo, K., Ashrafizadeh, M., et al. (2021) Flavonoids against the Sars-cov-2 Induced Inflammatory Storm. Biomedicine & Pharmacotherapy, 138, Article ID: 111430. https://doi.org/10.1016/j.biopha.2021.111430
|
[85]
|
Seadawy, M.G., Gad, A.F., Shamel, M., Elharty, B., Mohamed, M.F., Elfiky, A.A., Ahmed, A. and Zekri, A.R.N. (2021) In Vitro-Natural Compounds (Thymol, Carvacrol, Hesperidine, and Thymoquinone) against SARS-CoV-2 Strain Isolated from Egypt. Biomedical Journal of Scientific & Technical Research, 34, 26750-26757. https://doi.org/10.26717/BJSTR.2021.34.005552
|
[86]
|
Solnier, J. and Fladerer, J.-P. (2020) Flavonoids: A Complementary Approach to Conventional Therapy of COVID-19? Phytochemistry Reviews, 20, 773-795. https://doi.org/10.1007/s11101-020-09720-6
|